China In Vitro Diagnostics (IVD) Market Share to Boost During 2020-2025

China In Vitro Diagnostics Market and Forecast 2020-2025 is latest research study released by DPI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the China In Vitro Diagnostics Market.

Download Free Sample Report @

The in–vitro diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease testing and diagnosis in early stages of disease. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories. However, low reimbursement rate, absence of quality products by the local companies, population factors and foreign companies faces difficulty to enter the low end IVD products market are restraining the growth of this market.

Long–term Outlook: The China In Vitro Diagnostics Market is expected to reach more than US$ 10 Billion by 2021 with strong double digit growth rate from 2016 to 2021.

Enquire for customization in Report @:

China IVD Market: Segment wise Outlook

Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.

China IVD Market: Companies wise Outlook

Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi–auto and automatic biochemistry analyzers to low and mid–end market users.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market, market segments, company wise sales analysis, regulation, major distributors and laboratories of IVD and outlook of the Chinese IVD companies.

This report titled “China In Vitro Diagnostics(IVD) – Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021” has been analyzed from 10 viewpoints:

1. Market and Forecast (2010 – 2021)
2. Segment Wise Market and Forecast (2010 – 2021)
3. Company Wise IVD Sales and Forecast (2010 – 2021)
4. Regulation and its Latest Development
5. Future Prospects in Attractive In Vitro Diagnostics Segments
6. Regional Trends and Opportunities
7. Main Participants/Contributors
8. Major IVD Product Companies Outlook
9. Major Private Clinical Labs and Diagnostic Services Companies Outlook
10. Market Growth Drivers and Challenges

For More Information@

The following segments of the China In Vitro Diagnostics market are detailed with size and six year forecast:

  • Clinical Chemistry
  • Immunoassay
  • Molecular Testing
  • Self–Monitoring of Blood Glucose (SMBG)
  • Point of Care Testing (POCT)
  • Hematology
  • Coagulation
  • Microbiology

The following companies of the China In Vitro Diagnostics market are detailed with size and six year forecast:

  • Roche Diagnostics
  • Abbott Laboratories
  • Mindray Medical International Limited
  • Sysmex Corporation
  • Shanghai Kehua Bio–Engineering Co. Ltd.
  • Other Companies

The following Chinese companies of the China In Vitro Diagnostics market are detailed with company overview and its product portfolio:

  • Mindray Medical International Limited
  • Shanghai Fosun Pharmaceutical Group
  • Mingyuan Medicare
  • Da An Gene Co. Ltd.
  • Shanghai Kehua Bio–Engineering Co. Ltd.
  • Zhejiang D.a. Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • BGI – Shenzhen
  • OriGene Technologies

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web:
Direct Line: +91-766-764-8693

About Us:

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Spread the love

2 Replies to “China In Vitro Diagnostics (IVD) Market Share to Boost During 2020-2025”

Leave a Reply

Your email address will not be published. Required fields are marked *